Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells

Molecular Carcinogenesis

Volumn 45, Issue 10, 2006, Pages 752-763

  Konstantakopoulos, N ^a,b   Montgomery, K G ^c   Chamberlain, N ^c   Quinn, M A ^a,b   Baker, M S ^d   Rice, G E ^a,f   Georgiou, H M ^b,e   Campbell, I G ^c  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d MACQUARIE UNIVERSITY   (Australia)

^e MERCY HOSPITAL FOR WOMEN   (Australia)

^f BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Endometrial cancer; Genistein; Microarray; Phytoestrogen; Tumor suppression

Indexed keywords

ESTRADIOL; ESTROGEN; GENISTEIN; PHYTOESTROGEN;

ARTICLE; ASIAN; BREAST CANCER; CANCER CELL CULTURE; CANCER GENETICS; CANCER INCIDENCE; CARCINOGENESIS; CELL STRAIN; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENDOMETRIUM CANCER; FEMALE; FOOD INTAKE; GENE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; ISHIKAWA CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OVARY CANCER; PLEIOTROPY; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; SOYBEAN; STRESS; UNINDEXED SEQUENCE;

CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; UP-REGULATION;

GLYCINE MAX;

EID: 33749254048     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20187     Document Type: Article

References (47)

1. Wu AH, Ziegler RG, Nomura AM, et al. Soy intake and risk of breast cancer in Asians and Asian Americans. Am J Clin Nutr 1998;68:1437S-1443S.
2. Arena S, Rappa C, Del Frate E, Cenci S, Villani C. A natural alternative to menopausal hormone replacement therapy, Phytoestrogens. Minerva Ginecol 2002;54:53-57.
3. Fanti P, Monier-Faugere MC, Geng Z, et al. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int 1998;8:274-281.
4. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-4263.
5. Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5595.
6. Kang JL, Lee HW, Lee HS, et al. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. Am J Respir Crit Care Med 2001;164: 2206-2212.
7. Suzuki K, Koike H, Matsui H, et al. Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. Int J Cancer 2002;99: 846-852.
8. Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001;15:341-354.
9. Irvin WP, Rice LW, Berkowitz RS. Advances in the management of endometrial adenocarcinoma. J Reprod Med 2002;47:173-189; discussion 189-190.
10. Ohta H, Sakamoto H, Satoh K. In vitro effects of gonadotropin-releasing hormone (GnRH) analogue on cancer cell sensitivity to cis-platinum. Cancer Lett 1998;134:111-118.
11. Khan J, Simon R, Bittner M, et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 1998;58:5009-5013.
12. Yang YH, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002;30:e15.
13. Makela S, Santti R, Salo L, McLachlan JA. Phytoestrogens are partial estrogen agonists in the adult male mouse. Environ Health Perspect 1995;103:123-127.
14. Makela SI, Pylkkanen LH, Santti RS, Adlercreutz H. Dietary soybean may be antiestrogenic in male mice. J Nutr 1995;125:437-445.
15. Duan W, Kuo IC, Selvarajan S, Chua KY, Bay BH, Wong WS. Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma. Am J Respir Crit Care Med 2003;167:185-192.
16. Kawauchi K, Lazarus AH, Sanghera JS, Man GL, Pelech SL, Delovitch TL. Regulation of BCR- and PKC/Ca(2+)-mediated activation of the Raf1/MEK/MAPK pathway by protein-tyrosine kinase and -tyrosine phosphatase activities. Mol Immunol 1996;33:287-296.
17. Davis JN, Kucuk O, Sarkar FH. Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutr Cancer 1999;35: 167-174.
18. Li Y, Sarkar FH. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res 2002;8:2369-2377.
19. Balabhadrapathruni S, Thomas TJ, Yurkow EJ, Amenta PS, Thomas T. Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells. Oncol Rep 2000; 7:3-12.
20. Xu X, Harris KS, Wang HJ, Murphy PA, Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 1995;125:2307-2315.
21. Bloedon LT, Jeffcoat AR, Lopaczynski W, et al. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am J Clin Nutr 2002;76:1126-1137.
22. Busby MG, Jeffcoat AR, Bloedon LT, et al. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr 2002;75:126-136.
23. Coldham NG, Sauer MJ. Pharmacokinetics of [(14)C]Genistein in the rat: gender-related differences, potential mechanisms of biological action, and implications for human health. Toxicol Appl Pharmacol 2000;164:206-215.
24. Farhan H, Wahala K, Adlercreutz H, Cross HS. Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells. J Chromatogr B Analyt Technol Biomed Life Sci 2002;777: 261-268.
25. Frigo DE, Duong BN, Melnik LI, et al. Flavonoid phytochemical regulate activator protein-1 signal transduction pathways in endometrial and kidney stable cell lines. J Nutr 2002;132:1848-1853.
26. Li Y, Sarkar FH. Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Lett 2002;186:157-164.
27. Rice L, Samedi VG, Medrano TA, et al. Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts. Prostate 2002;52:201-212.
28. Ling YH, Tornos C, Perez-Soler R. Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis. J Biol Chem 1998;273:18984-18991.
29. Park MH, Wolff EC, Folk JE. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. Biofactors 1993;4:95-104.
30. Giannakakou P, Sackett D, Fojo T. Tubulin/microtubules: still a promising target for new chemotherapeutic agents. J Natl Cancer Inst 2000;92:182-183.
31. Gonias SL, Hembrough TA, Sankovic M. Cytokeratin 8 functions as a major plasminogen receptor in select epithelial and carcinoma cells. Front Biosci 2001;6:D1403-D1411.
32. Hembrough TA, Li L, Gonias SL. Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator. J Biol Chem 1996;271:25684-25691.
33. Kimura M, Ishihama A. Tfg3, a subunit of the general transcription factor TFIIF in Schizosaccharomyces pombe, functions under stress conditions. Nucleic Acids Res 2004; 32:6706-6715.
34. Purrello M, Di Pietro C, Rapisarda A, et al. Genes for human general transcription initiation factors TFIIIB, TFIIIB-associated proteins, TFIIIC2 and PTF/SNAPC: functional and positional candidates for tumour predisposition or inherited genetic diseases? Oncogene 2001;20:4877-4883.
35. Matsuda S, Rouault J, Magaud J, Berthet C. In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett 2001;497:67-72.
36. Kawakubo H, Carey JL, Brachtel E, et al. Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. Oncogene 2004;23:8310-8319.
37. Meinhold-Heerlein I, Bauerschlag D, Hilpert F, et al. Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential. Oncogene 2005;24:1053-1065.
38. Adams J, Cuthbert-Heavens D, Bass S, Knowles MA. Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity. Cancer Lett 2005;220:137-144.
39. Peterson G, Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 1991;179:661-667.
40. Fioravanti L, Cappelletti V, Miodini P, Ronchi E, Brivio M, Di Fronzo G. Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro. Cancer Lett 1998;130:143-152.
41. Hopert AC, Beyer A, Frank K, Strunck E, Wunsche W, Vollmer G. Characterization of estrogenicity of phytoestrogens in an endometrial-derived experimental model. Environ Health Perspect 1998;106:581-586.
42. Santell RC, Kieu N, Helferich WG. Genistein inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice. J Nutr 2000;130:1665-1669.
43. An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC. Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 2001;276:17808-17814.
44. Morito K, Hirose T, Kinjo J, et al. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 2001;24:351-356.
45. Kayisli UA, Aksu CA, Berkkanoglu M, Arici A. Estrogenicity of isoflavones on human endometrial stromal and glandular cells. J Clin Endocrinol Metab 2002;87:5539-5544.
46. Naciff JM, Jump ML, Torontali SM, et al. Gene expression profile induced by 17alpha-ethynyl est. Toxicol Sci 2002; 68:184-199.
47. Garcia-Lopez P, Rodriguez-Dorantes M, Perez-Cardenas E, Cerbon M, Mohar-Betancourt A. Cancer Chemother Pharmacol 2004.